Point mutations in the mdr1 promoter of human osteosarcomas are associated with In vitro responsiveness to multidrug resistance relevant drugs
- 31 December 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (10), 1541-1545
- https://doi.org/10.1016/0959-8049(94)00287-f
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Expression of the mdr1 gene in bone and soft tissue sarcomas of adult patientsEuropean Journal Of Cancer, 1993
- Activation of the human mdr1 gene promoter in differentiated neuroblastsInternational Journal of Cancer, 1993
- Involvement of protein kinase in environmental stress‐induced activation of human multidrug resistance 1 (MDR1) gene promoterFEBS Letters, 1993
- Function and Regulation of the Human Multidrug Resistance GeneAdvances in Cancer Research, 1992
- Multidrug resistance (mdr) genes in human cancerBritish Journal of Cancer, 1991
- The direct activation of human multidrug resistance gene (MDR1) by anticancer agentsBiochemical and Biophysical Research Communications, 1989
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) geneCell, 1988
- Electroporation for the efficient transfection of mammalian cells with DNANucleic Acids Research, 1987
- Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell, 1986